Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
This is the first dividend that the Company has declared and will pay onits Series B stock, and such payment will cover the amount of all dividendsaccrued from May 9, 2008, the original issuance date of the Series B stock,through September 30, 2008.
For more information about Inverness Medical Innovations, please visit ourwebsite at http://www.invernessmedical.com.
By developing new capabilities in near-patient diagnosis, monitoring andhealth management, Inverness Medical Innovations enables individuals to takecharge of improving their health and quality of life. A global leader inrapid point-of-care diagnostics, Inverness' products, as well as its newproduct development efforts, focus on infectious disease, cardiology,oncology, drugs of abuse and women's health. Inverness is headquartered inWaltham, Massachusetts.
SOURCE Inverness Medical Innovations, Inc.
You May Also Like